logo

Arena Pharmaceutical Inc. (ARNA)



Trade ARNA now with
  Date
  Headline
11/4/2021 5:22:21 PM Arena Pharma Q3 Loss/share $3.21 Vs. Loss $1.69 Year Ago
8/5/2021 5:00:21 PM Arena Pharma Q2 Loss/share $2.40 Vs. Loss $1.61 Year Ago
8/5/2021 7:06:55 AM Second Genome, Arena Pharma Collaborate To Identify Gastrointestinal Biomarkers
12/11/2020 9:01:26 AM Arena Pharmaceuticals To Present Data From The Phase 2b ADVISE Trial - Late-Breaker
12/8/2020 8:39:53 AM Arena Pharma Says Achieves Target Enrollment For Etrasimod Phase 3 ELEVATE UC 52 Trial
11/9/2020 4:09:16 PM Arena Pharmaceuticals Q3 Loss/share $1.69 Vs. Loss $.46 Year Ago
11/9/2020 4:04:46 PM Arena Says Etrasimod Did Not Meet Ph 2b Primary Endpoint Of EASI Change From Baseline At Week 12
10/28/2020 8:33:50 AM Arena Pharma Announces Launch Of Longboard Pharmaceuticals With $56 Mln Financing
10/20/2020 4:03:49 PM Arena Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/1/2020 8:31:56 AM Arena Completes Full Enrollment Of Phase 2b CAPTIVATE Trial Evaluating Olorinab